Cerus Corporation
Cerus Corporation（CERS）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · CERS · 截至 2026年6月9日
活动摘要
买入笔数
1
P-Purchase only
卖出笔数
16
近12个月
买卖比
0.06
Buy/Sell (by trades)
整体情绪
Cerus Corporation内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
CERS 季度内部人买卖趋势
CERS 内幕交易卖出 · CERS 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · CERS CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
CERS 高管卖出股份 · CERS 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 2, 2026 | Lucena Ann Director | Award | 60,000 | — | Form 4 |
| Jun 2, 2026 | BJERKHOLT ERIC Director | Award | 60,000 | — | Form 4 |
| Jun 2, 2026 | NACHTSHEIM JAMI K Director | Award | 60,000 | — | Form 4 |
| May 29, 2026 | Jayaraman Vivek K COO | Sale | 16,667 | $50K | Form 4 |
| Jun 2, 2026 | Witney Frank Director | Award | 60,000 | — | Form 4 |
| Jun 2, 2026 | Gregory Dean A. Director | Award | 60,000 | — | Form 4 |
| Jun 2, 2026 | Shan Hua Director | Award | 60,000 | — | Form 4 |
| May 1, 2026 | Jayaraman Vivek K COO | Sale | 16,667 | $50K | Form 4 |
| Apr 1, 2026 | Green Kevin Dennis CFO | Award | 200,000 | — | Form 4 |
| Apr 1, 2026 | Jensen Chrystal Chief Legal Officer | Award | 200,000 | — | Form 4 |
| Mar 12, 2025 | Jensen Chrystal Chief Legal Officer | Sale | 113,008 | $187K | Form 4 |
| Mar 12, 2026 | Jayaraman Vivek K COO | Sale | 165,200 | $274K | Form 4 |
| Mar 12, 2026 | Greenman William Mariner President and CEO · Director | Sale | 447,757 | $742K | Form 4 |
| Mar 12, 2026 | Green Kevin Dennis CFO | Sale | 127,544 | $211K | Form 4 |
| Mar 12, 2026 | Benjamin Richard J Chief Medical Officer | Sale | 101,740 | $169K | Form 4 |
| Mar 5, 2026 | Green Kevin Dennis CFO | Award | 63,854 | — | Form 4 |
| Mar 5, 2026 | Green Kevin Dennis CFO | Sale | 55,225 | $114K | Form 4 |
| Mar 6, 2026 | Green Kevin Dennis CFO | Sale | 27,796 | $56K | Form 4 |
| Mar 5, 2026 | Benjamin Richard J Chief Medical Officer | Award | 55,220 | — | Form 4 |
| Mar 5, 2026 | Benjamin Richard J Chief Medical Officer | Sale | 61,233 | $126K | Form 4 |
| Mar 6, 2026 | Benjamin Richard J Chief Medical Officer | Sale | 24,235 | $49K | Form 4 |
| Mar 9, 2026 | Benjamin Richard J Chief Medical Officer | Sale | 40,426 | $76K | Form 4 |
| Mar 5, 2026 | Jensen Chrystal Chief Legal Officer | Award | 55,220 | — | Form 4 |
| Mar 6, 2026 | Jensen Chrystal Chief Legal Officer | Sale | 30,845 | $62K | Form 4 |
| Mar 5, 2026 | Jayaraman Vivek K COO | Award | 80,320 | — | Form 4 |
Greenman William Mariner
President and CEO · Director
日期
Mar 12
股数
447,757
均价
$1.66
总金额
$742K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 CERS 内幕交易
CERS 内幕交易
Cerus Corporation（CERS）内幕交易数据来源于公司内部人（包括Jayaraman Vivek K (COO), Green Kevin Dennis (CFO), Benjamin Richard J (Chief Medical Officer)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。CERS内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Cerus Corporation机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
CERS 内幕交易 · 5个问题Cerus Corporation（CERS）的内部人包括高管和董事，如Jayaraman Vivek K (COO), Green Kevin Dennis (CFO), Benjamin Richard J (Chief Medical Officer)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026